DE60110084D1 - Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält - Google Patents

Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält

Info

Publication number
DE60110084D1
DE60110084D1 DE60110084T DE60110084T DE60110084D1 DE 60110084 D1 DE60110084 D1 DE 60110084D1 DE 60110084 T DE60110084 T DE 60110084T DE 60110084 T DE60110084 T DE 60110084T DE 60110084 D1 DE60110084 D1 DE 60110084D1
Authority
DE
Germany
Prior art keywords
nitrogen
iron
precursor
composition containing
oxidant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60110084T
Other languages
German (de)
English (en)
Inventor
Bernard Dugas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Isocell SA
Original Assignee
Isocell SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isocell SA filed Critical Isocell SA
Application granted granted Critical
Publication of DE60110084D1 publication Critical patent/DE60110084D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40Transferrins, e.g. lactoferrins, ovotransferrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60110084T 2000-07-27 2001-07-27 Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält Expired - Lifetime DE60110084D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0009883A FR2812200B1 (fr) 2000-07-27 2000-07-27 Composition contenant une proteine complexant le fer et un precurseur du metabolisme du monoxyde d'azote et/ou un donneur chimique de monoxyde d'azote ; et utilisations
PCT/FR2001/002469 WO2002009740A1 (fr) 2000-07-27 2001-07-27 Composition contenant une proteine complexant le fer et un precurseur du metabolisme du monoxyde d'azote et/ou un donneur chimique de monoxyde d'azote et utilisations

Publications (1)

Publication Number Publication Date
DE60110084D1 true DE60110084D1 (de) 2005-05-19

Family

ID=8852998

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60110084T Expired - Lifetime DE60110084D1 (de) 2000-07-27 2001-07-27 Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält

Country Status (8)

Country Link
US (1) US6984624B2 (enExample)
EP (1) EP1303296B1 (enExample)
JP (1) JP2004520264A (enExample)
AT (1) ATE292978T1 (enExample)
AU (1) AU2001279922A1 (enExample)
DE (1) DE60110084D1 (enExample)
FR (1) FR2812200B1 (enExample)
WO (1) WO2002009740A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10215315A1 (de) * 2002-04-05 2003-11-20 Aventis Behring Gmbh Intellect Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels
ES2436214T3 (es) 2003-09-12 2013-12-27 Or-Nim Medical Ltd. Monitorización óptica no invasiva de una región de interés
DE602004001972T2 (de) * 2004-04-23 2007-09-06 Abb Research Ltd. Modell und Regelung eines Müllverbrennungsverfahrens
MX2007004036A (es) * 2004-10-08 2007-05-24 Unilever Nv Complejo de hierro para uso en el tratamiento y/o prevencion de trastornos nutricionales.
JPWO2006106805A1 (ja) * 2005-03-30 2008-09-11 協和醗酵工業株式会社 物質の保存安定性向上方法
US20090202613A1 (en) * 2008-02-11 2009-08-13 Tabatchnick Fine Foods, Inc. Nutritionally Enhanced Therapeutic Preventative Food Supplement and Method of Making Same
JP5022454B2 (ja) * 2008-02-14 2012-09-12 森永乳業株式会社 卵巣機能改善剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09508097A (ja) * 1993-11-02 1997-08-19 アメリカ合衆国 虚血再灌流傷害における保護剤としての酸化窒素放出化合物の使用
US5827729A (en) * 1996-04-23 1998-10-27 Advanced Tissue Sciences Diffusion gradient bioreactor and extracorporeal liver device using a three-dimensional liver tissue
EP1017407A2 (en) * 1997-02-03 2000-07-12 Pharming Intellectual Property BV Useful properties of human lactoferrin and variants thereof

Also Published As

Publication number Publication date
EP1303296A1 (fr) 2003-04-23
FR2812200A1 (fr) 2002-02-01
US6984624B2 (en) 2006-01-10
AU2001279922A1 (en) 2002-02-13
WO2002009740A1 (fr) 2002-02-07
FR2812200B1 (fr) 2003-01-03
JP2004520264A (ja) 2004-07-08
ATE292978T1 (de) 2005-04-15
US20040033945A1 (en) 2004-02-19
EP1303296B1 (fr) 2005-04-13

Similar Documents

Publication Publication Date Title
WO2007035757A3 (en) Composition and method for treating iron deficiency anemia
AU8188987A (en) Improved metal complex-containing pharmaceutical agents
UA34768A (uk) Склад для обробки пар тертя
NO20015991D0 (no) Bisykliske polyaminoacid-metallkomplekser, fremgangsmåter for fremstilling av disse og anvendelse i medisinsk billeddannelse
NO954440D0 (no) 2 pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og derivater derav, for anvendelse som kontrastmidler
DE69924232D1 (de) Stabilisierte insulin-zubereitungen
EP1311269A4 (en) PROCESS FOR USE OF DIKETOPIPERAZINES AND COMPOSITIONS THEREOF CONTAINING THEM
MY136095A (en) Use of human anti-ctla-4 antibodies for treatment of cancer
DE69910045D1 (de) Neue heteroaromatische fructose 1,6-bisphosphatase inhibitoren
DE69914357D1 (de) Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
DE69717447D1 (de) Reduzierung der kardiotoxizität von antitumormitteln mit manganverbindungen
AU2496199A (en) Copolymer compositions for oral delivery
ATE143266T1 (de) Komplexe und chelate des azithromycins als antiulcus-mittel
ATE292978T1 (de) Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält
ATE240303T1 (de) 1,2,4-triazol-3-thion verbindungen
BR9912547A (pt) (poli)isocianatos ocultos mistos
ES2004799A6 (es) Agente de limpieza liquido granulado o pulverulento especialmente para maquinas lavavajillas asi como su utilizacion
CA2481593A1 (en) Biologically stable liquid composition of fviii, of vwf or of fviii/vwf complex of human origin
ATE245028T1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
WO1999011256A8 (en) L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
ATE353212T1 (de) Mittel zum färben von menschlichem keratinmaterial, enthaltend mindestens zwei komponenten und färbeverfahren
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
TW200637603A (en) Oral treatment compositions containing anti-adhesion agent, antibacterial agent and incompatible compound
GR1004016B (el) Αναβραζοντα δισκια, που περιεχουν ως δραστικο συστατικο συμπλοκες ενωσεις σιδηρου, για την θεραπεια των σιδηροπενικων αναιμιων

Legal Events

Date Code Title Description
8332 No legal effect for de